Literature DB >> 12613754

Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. II. Selection of a strain of virus for release.

P J Kerr1, J C Merchant, L Silvers, G M Hood, A J Robinson.   

Abstract

To be able to study the dynamics of myxoma virus spread following a release in the field, a strain of virus is required that is both highly transmissible and readily differentiated from other field strains. Eight strains of virus of known virulence for laboratory rabbits and with previously mapped and sequenced restriction fragment length polymorphisms, were used to infect groups of seronegative wild rabbits. Based on these trials, and on the nature of the DNA polymorphism, a virus designated Brooklands/2-93 was chosen as a strain suitable for experimental release. These trials confirmed that resistance to myxomatosis within wild rabbit populations continues to be substantial and that some rabbits are highly resistant. These rabbits probably have little role in transmission of virus. Most of the virus strains tested induced very small or invisible primary lesions at the inoculation site. Thus the secondary skin sites such as eyelids, face and ears may be critical for transmission.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12613754      PMCID: PMC2869947          DOI: 10.1017/s0950268802007860

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  8 in total

1.  Molecular methods in detection and epidemiologic studies of rabbit and hare viruses: a review.

Authors:  Ewa Kwit; Artur Rzeżutka
Journal:  J Vet Diagn Invest       Date:  2019-05-25       Impact factor: 1.279

2.  Next step in the ongoing arms race between myxoma virus and wild rabbits in Australia is a novel disease phenotype.

Authors:  Peter J Kerr; Isabella M Cattadori; June Liu; Derek G Sim; Jeff W Dodds; Jason W Brooks; Mary J Kennett; Edward C Holmes; Andrew F Read
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

3.  Molecular characterisation of virulence graded field isolates of myxoma virus.

Authors:  Kevin P Dalton; Ines Nicieza; Aroa Baragaño; Jose Manuel Martín Alonso; Francisco Parra
Journal:  Virol J       Date:  2010-02-26       Impact factor: 4.099

4.  Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread.

Authors:  Peter J Kerr; Matthew B Rogers; Adam Fitch; Jay V Depasse; Isabella M Cattadori; Alan C Twaddle; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes; Elodie Ghedin
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

5.  Evolutionary history and attenuation of myxoma virus on two continents.

Authors:  Peter J Kerr; Elodie Ghedin; Jay V DePasse; Adam Fitch; Isabella M Cattadori; Peter J Hudson; David C Tscharke; Andrew F Read; Edward C Holmes
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

Review 6.  Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.

Authors:  Peter J Kerr; June Liu; Isabella Cattadori; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  Viruses       Date:  2015-03-06       Impact factor: 5.048

7.  Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia.

Authors:  Peter J Kerr; Isabella M Cattadori; Matthew B Rogers; Adam Fitch; Adam Geber; June Liu; Derek G Sim; Brian Boag; John-Sebastian Eden; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  PLoS Pathog       Date:  2017-03-02       Impact factor: 6.823

8.  Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit.

Authors:  Fábio A Abade Dos Santos; Carina L Carvalho; Pâmela C L G Valente; Henrique Armés; Sylvia S Reemers; Maria C Peleteiro; Inés Calonge Sanz; Kevin P Dalton; Francisco Parra; Margarida D Duarte
Journal:  Vaccines (Basel)       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.